Market Expansion TheraClear is already used in more than 20 countries, indicating readiness for scaled international sales efforts. Target expansion into additional clinics, spas, and dermatology practices in underserved regions with rising demand for non-pharmaceutical acne solutions.

Product Differentiation The TheraClear Acne System combines gentle vacuum with broadband light and is FDA-cleared for a wide range of acne types, offering a non-pharmaceutical, painless treatment with rapid visible results. Position this as a premium, low-risk solution to drive larger order sizes from clinics seeking standout aesthetics offerings.

Revenue Growth Current revenue is under $1M with a lean team, suggesting high upside potential through channel partnerships, resellers, and bundled packages for clinics and spa networks. Propose tiered pricing, volume discounts, and onboarding incentives to accelerate adoption.

Tech & Support Reliance on a skilled product development foundation and recognizable tech stack indicates readiness for ongoing product updates and service support. Offer comprehensive training, marketing materials, and remote support packages to reduce adoption friction for small practices.

Competitive Position As a leading non-pharmaceutical acne system in multiple markets, TheravaClear can leverage its FDA clearance and efficacy claims to target mid-market dermatology clinics and aesthetic centers competing with larger players. Develop a competitive sweep with case studies, ROI calculators, and trial programs to win share against larger incumbents.